% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • zhanyong_1 zhanyong_1 Oct 19, 2012 7:40 AM Flag

    AEGR is in good cash position

    There last offering was on June 14, 2012. It was 3,400,000 shares of common stock at a price to the public of $14.75. This gave them a net proceeds of $47.3 million, after deducting underwriting discounts and commissions. This should last them more than a year, well into after FDA approval by the end of this year. The facts are all in their Website. Shorties are trying to create fear by lies, longs be aware.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • FDA advisers vote 13-2 that Aegerion data sufficient for approval. Experts all agreed that it makes FDA approval pretty much a sure thing. The company has prepared for the approval and the commercialization of their drug for a long time(see their quarterly report) and the sale would be immediate after approval. Cash flow could be quick and strong starting 3 months from now.

1.8699+0.0499(+2.74%)12:18 PMEDT